 |
Catalogue |
 |
|
Main Products |
|
|
|
|
Products |
|
No. |
Product Name |
CAS No. |
Spec |
Price |
|
| MM0173.04 |
Losartan Imp. G (EP) |
76-84-6 |
|
|
| MM0168.16 |
Losartan Imp. H (EP) |
133909-99-6 |
|
|
| MM0168.17 |
Losartan Imp. I (EP) |
n/aA |
|
|
| MM0168.18 |
Losartan Imp. J (EP) |
1006062-27-6 |
|
|
| MM0168.11 |
Losartan Butyl Ether |
n/a |
|
|
| MM0168.12 |
Losartan Methyl Ether |
114798-94-6 |
|
|
| MM0050.00 |
Lovastatin |
75330-75-5 |
|
|
| MM0377.00 |
Lovastatin Imp. A (EP) |
73573-88-3 |
|
|
| MM0050.01 |
Lovastatin Imp. B (EP) as Sodium Salt |
75225-50-2 |
|
|
| MM0050.03 |
Lovastatin Imp. C (EP) |
109273-98-5 |
|
|
| MM0460.10 |
Malic Acid Imp. A (EP) |
110-17-8 |
|
|
| MM0820.00 |
Maprotiline Hydrochloride |
10347-81-6 |
|
|
| MM0820.01 |
Maprotiline Hydrochloride Imp. A (EP) |
38849-09-1 |
|
|
| MM0820.02 |
Maprotiline Hydrochloride Imp. B (EP) as Hydrochloride |
n/a |
|
|
| MM0820.03 |
Maprotiline Hydrochloride Imp. C (EP) as Hydrochloride |
92202-51-2 |
|
|
| MM0820.04 |
Maprotiline Hydrochloride Imp. D (EP) as Hydrochloride |
38849-14-8 |
|
|
| MM0820.05 |
Maprotiline Hydrochloride Imp. E (EP) as Hydrochloride |
23941-45-9 |
|
|
| MM0882.02 |
Mebendazole Imp. B (EP) |
21472-33-3 |
|
|
| MM0882.03 |
Mebendazole Imp. C (EP) |
66066-76-0 |
|
|
| MM0882.04 |
Mebendazole Imp. D (EP) |
132119-11-0 |
|
|
|
|
|
